Classification of ambiguous mutations in DNA mismatch repair genes identified in a population-based study of colorectal cancer

Human Mutation

Volumn 29, Issue 3, 2008, Pages 367-374

  Barnetson, Rebecca A ^a   Cartwright, Nicola ^a   Van Vliet, Annelot ^a   Haq, Naila ^a   Drew, Kate ^a   Farrington, Susan ^a   Williams, Nicola ^a   Warner, Jon ^a   Campbell, Harry ^b   Porteous, Mary E ^a   Dunlop, Malcolm G ^a  

^a WESTERN GENERAL HOSPITAL   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Colorectal cancer; DNA mismatch repair; HNPCC; Lynch syndrome; MLH1; MSH2; MSH6

Indexed keywords

DNA MISMATCH REPAIR PROTEIN; GENE PRODUCT; MESSENGER RNA; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BIOINFORMATICS; CANCER PATIENT; COLORECTAL CANCER; CONTROLLED STUDY; FAMILY HISTORY; FEMALE; GENE; GENE FREQUENCY; GENE IDENTIFICATION; GENE MUTATION; GENETIC POLYMORPHISM; GENETIC SCREENING; GENETIC VARIABILITY; GERM LINE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE INSTABILITY; MISMATCH REPAIR; MISSENSE MUTATION; MLH1 GENE; MSH2 GENE; MSH6 GENE; NUCLEOTIDE SEQUENCE; PATHOGENICITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN EXPRESSION; RNA SPLICING; SCORING SYSTEM;

EID: 40549109545     PISSN: 10597794     EISSN: None     Source Type: Journal    
DOI: 10.1002/humu.20635     Document Type: Article

References (57)

1. Aaltonen LA, Salovaara R, Kristo P, Canzian F, Hemminki A, Peltomaki P, Chadwick RB, Kaariainen H, Eskelinen M, Jarvinen H, Mecklin JP, de la Chapelle A. 1998. Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease. N Engl J Med 338: 1481–1487.
2. Akiyama Y, Sato H, Yamada T, Nagasaki H, Tsuchiya A, Abe R, Yuasa Y. 1997. Germ‐line mutation of the hMSH6/GTBP gene in an atypical hereditary nonpolyposis colorectal cancer kindred. Cancer Res 57: 3920–3923.
3. Barnetson RA, Tenesa A, Farrington SM, Nicholl ID, Cetnarskyj R, Porteous ME, Campbell H, Dunlop MG. 2006. Identification and survival of carriers of mutations in DNA mismatch‐repair genes in colorectal cancer. N Engl J Med 354: 2751–2763.
4. Belvederesi L, Bianchi F, Loretelli C, Gagliardini D, Galizia E, Bracci R, Rosati S, Bearzi I, Viel A, Cellerino R, Porfiri E. 2006. Assessing the pathogenicity of MLH1 missense mutations in patients with suspected hereditary nonpolyposis colorectal cancer: correlation with clinical, genetic and functional features. Eur J Hum Genet 14: 853–859.
5. Berends MJ, Wu Y, Sijmons RH, Mensink RG, van der Sluis T, Hordijk‐Hos JM, de Vries EG, Hollema H, Karrenbeld A, Buys CH, van der Zee AG, Hofstra RM, Kleibeuker JH. 2002. Molecular and clinical characteristics of MSH6 variants: an analysis of 25 index carriers of a germline variant. Am J Hum Genet 70: 26–37.
6. Blasi MF, Ventura I, Aquilina G, Degan P, Bertario L, Bassi C, Radice P, Bignami M. 2006. A human cell‐based assay to evaluate the effects of alterations in the MLH1 mismatch repair gene. Cancer Res 66: 9036–9044.
7. Boland CR, Thibodeau SN, Hamilton SR, Sidransky D, Eshleman JR, Burt RW, Meltzer SJ, Rodriguez‐Bigas MA, Fodde R, Ranzani GN, Srivastava S. 1998. A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 58: 5248–5257.
8. Bronner CE, Baker SM, Morrison PT, Warren G, Smith LG, Lescoe MK, Kane M, Earabino C, Lipford J, Lindblom A, Tannergård P, Bollag R, Godwin A, Ward D, Nordenskjosolld M, Fishel R, Kolodner R, Liskay RM. 1994. Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non‐polyposis colon cancer. Nature 368: 258–261.
9. Charames GS, Millar AL, Pal T, Narod S, Bapat B. 2000. Do MSH6 mutations contribute to double primary cancers of the colorectum and endometrium? Hum Genet 107: 623–629.
10. Cravo M, Afonso AJ, Lage P, Albuquerque C, Maia L, Lacerda C, Fidalgo P, Chaves P, Cruz C, Nobre‐Leitao C. 2002. Pathogenicity of missense and splice site mutations in hMSH2 and hMLH1 mismatch repair genes: implications for genetic testing. Gut 50: 405–412.
11. de Abajo AS, de la Hoya M, Tosar A, Godino J, Fernandez JM, Asenjo JL, Villamil BP, Segura PP, Diaz‐Rubio E, Caldes T. 2005. Low prevalence of germline hMSH6 mutations in colorectal cancer families from Spain. World J Gastroenterol 11: 5770–5776.
12. Dieumegard B, Grandjouan S, Sabourin JC, Le Bihan ML, Lefrere I, Bellefqih, Pignon JP, Rougier P, Lasser P, Benard J, Couturier D, Bressac‐de Paillerets B. 2000. Extensive molecular screening for hereditary non‐polyposis colorectal cancer. Br J Cancer 82: 871–880.
13. Drotschmann K, Clark AB, Kunkel TA. 1999. Mutator phenotypes of common polymorphisms and missense mutations in MSH2. Curr Biol 9: 907–910.
14. Dunlop MG, Farrington SM, Carothers AD, Wyllie AH, Sharp L, Burn J, Liu B, Kinzler KW, Vogelstein B. 1997. Cancer risk associated with germline DNA mismatch repair gene mutations. Hum Mol Genet 6: 105–110.
15. Ellison AR, Lofing J, Bitter GA. 2001. Functional analysis of human MLH1 and MSH2 missense variants and hybrid human‐yeast MLH1 proteins in Saccharomyces cerevisiae. Hum Mol Genet 10: 1889–1900.
16. Farrington SM, Lin‐Goerke J, Ling J, Wang Y, Burczak JD, Robbins DJ, Dunlop MG. 1998. Systematic analysis of hMSH2 and hMLH1 in young colon cancer patients and controls. Am J Hum Genet 63: 749–759.
17. Fishel R, Lescoe MK, Rao MR, Copeland NG, Jenkins NA, Garber J, Kane M, Kolodner R. 1993. The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer [published erratum appears in Cell 1994 Apr 8;77(1):167]. Cell 75: 1027–1038.
18. Froggatt NJ, Brassett C, Koch DJ, Evans DG, Hodgson SV, Ponder BA, Maher ER. 1996. Mutation screening of MSH2 and MLH1 mRNA in hereditary non‐polyposis colon cancer syndrome. J Med Genet 33: 726–730.
19. Genuardi M, Anti M, Capozzi E, Leonardi F, Fornasarig M, Novella E, Bellacosa A, Valenti A, Gasbarrini GB, Roncucci L, Benatti P, Pereesepe A, Ponz de Leon M, Coco C, de Paoli A, Valentini M, Boiocchi M, Neri G, Viel A. 1998. MLH1 and MSH2 constitutional mutations in colorectal cancer families not meeting the standard criteria for hereditary nonpolyposis colorectal cancer. Int J Cancer 75: 835–839.
20. Genuardi M, Carrara S, Anti M, Ponz de Leon M, Viel A. 1999. Assessment of pathogenicity criteria for constitutional missense mutations of the hereditary nonpolyposis colorectal cancer genes MLH1 and MSH2. Eur J Hum Genet 7: 778–782.
21. Guerrette S, Acharya S, Fishel R. 1999. The interaction of the human MutL homologues in hereditary nonpolyposis colon cancer. J Biol Chem 274: 6336–6341.
22. Hampel H, Frankel WL, Martin E, Arnold M, Khanduja K, Kuebler P, Nakagawa H, Sotamaa K, Prior TW, Westman J, Panescu J, Fix D, Lockman J, Comeras I, de la Chapelle A. 2005. Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer). N Engl J Med 352: 1851–1860.
23. Heinimann K, Scott RJ, Buerstedde JM, Weber W, Siebold K, Attenhofer M, Muller H, Dobbie Z. 1999. Influence of selection criteria on mutation detection in patients with hereditary nonpolyposis colorectal cancer. Cancer 85: 2512–2518.
24. Herfarth KK, Kodner IJ, Whelan AJ, Ivanovich JL, Bracamontes JR, Wells SA, Jr, Goodfellow PJ. 1997. Mutations in MLH1 are more frequent than in MSH2 in sporadic colorectal cancers with microsatellite instability. Genes Chromosomes Cancer 18: 42–49.
25. Herman JG, Umar A, Polyak K, Graff JR, Ahuja N, Issa JPJ, Markowitz S, Willson JKV, Hamilton SR, Kinzler KW, Kane MF, Kolodner RD, Vogelstein B, Kunkel TA, Baylin SB. 1998. Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma. Proc Natl Acad Sci USA 95: 6870–6875.
26. Jakubowska A, Gorski B, Kurzawski G, Debniak T, Hadaczek P, Cybulski C, Kladny J, Oszurek O, Scott RJ, Lubinski J. 2001. Optimization of experimental conditions for RNA‐based sequencing of MLH1 and MSH2 genes. Hum Mutat 17: 52–60.
27. Kariola R, Raevaara TE, Lonnqvist KE, Nystrom‐Lahti M. 2002. Functional analysis of MSH6 mutations linked to kindreds with putative hereditary non‐polyposis colorectal cancer syndrome. Hum Mol Genet 11: 1303–1310.
28. Kolodner RD, Tytell JD, Schmeits JL, Kane MF, Gupta RD, Weger J, Wahlberg S, Fox EA, Peel D, Ziogas A, Garber JE, Syngal S, Anton‐Culver H, Li FP. 1999. Germ‐line MSH6 mutations in colorectal cancer families. Cancer Res 59: 5068–5074.
29. Kondo E, Suzuki H, Horii A, Fukushige S. 2003. A yeast two‐hybrid assay provides a simple way to evaluate the vast majority of hMLH1 germ‐line mutations. Cancer Res 63: 3302–3308.
30. Kowalski LD, Mutch DG, Herzog TJ, Rader JS, Goodfellow PJ. 1997. Mutational analysis of MLH1 and MSH2 in 25 prospectively‐acquired RER+endometrial cancers. Genes Chromosomes Cancer 18: 219–227.
31. Lagerstedt Robinson K, Liu T, Vandrovcova J, Halvarsson B, Clendenning M, Frebourg T, Papadopoulos N, Kinzler KW, Vogelstein B, Peltomaki P, Kolodner RD, Nilbert M, Lindblom A. 2007. Lynch syndrome (hereditary nonpolyposis colorectal cancer) diagnostics. J Natl Cancer Inst 99: 291–299.
32. Leach FS, Nicolaides NC, Papadopoulos N, Liu B, Jen J, Parsons R, Peltomaki P, Sistonen P, Aaltonen LA, Nystromlahti M, Guan XY, Zhang J, Meltzer PS, Yu JW, Kao FT, Chen DJ, Cerosaletti KM, Fournier REK, Todd S, Lewis T, Leach RJ, Naylor SL, Weissenbach J, Mecklin JP, Jarvinen H, de la Chapelle A, Kinzler KW, Vogelstein B. 1993. Mutations of a muts homolog in hereditary nonpolyposis colorectal cancer. Cell 75: 1215–1225.
33. Lipkin SM, Rozek LS, Rennert G, Yang W, Chen PC, Hacia J, Hunt N, Shin B, Fodor S, Kokoris M, Greenson JK, Fearon E, Lynch H, Collins F, Gruber SB. 2004. The MLH1 D132H variant is associated with susceptibility to sporadic colorectal cancer. Nat Genet 36: 694–699.
34. Liu T, Stathopoulos P, Lindblom P, Rubio C, Wasteson Arver B, Iselius L, Holmberg E, Gronberg H, Lindblom A. 1998. MSH2 codon 322 Gly to Asp seems not to confer an increased risk for colorectal cancer susceptibility. Eur J Cancer 34: 1981.
35. Liu T, Tannergard P, Hackman P, Rubio C, Kressner U, Lindmark G, Hellgren D, Lambert B, Lindblom A. 1999. Missense mutations in hMLH1 associated with colorectal cancer. Hum Genet 105: 437–441.
36. Mauillon JL, Michel P, Limacher JM, Latouche JB, Dechelotte P, Charbonnier F, Martin C, Moreau V, Metayer J, Paillot B, Frebourg T. 1996. Identification of novel germline hMLH1 mutations including a 22 kb Alu‐mediated deletion in patients with familial colorectal cancer. Cancer Res 56: 5728–5733.
37. Muller‐Koch Y, Kopp R, Lohse P, Baretton G, Stoetzer A, Aust D, Daum J, Kerker B, Gross M, Dietmeier W, Holinski‐Feder E. 2001. Sixteen rare sequence variants of the hMLH1 and hMSH2 genes found in a cohort of 254 suspected HNPCC (hereditary nonpolyposis colorectal cancer) patients: mutations or polymorphisms? Eur J Med Res 6: 473–482.
38. Ng PC, Henikoff S. 2001. Predicting deleterious amino acid substitutions. Genome Res 11: 863–874.
39. Nystrom‐Lahti M, Perrera C, Raschle M, Panyushkina‐Seiler E, Marra G, Curci A, Quaresima B, Costanzo F, D'Urso M, Venuta S, Jiricny J. 2002. Functional analysis of MLH1 mutations linked to hereditary nonpolyposis colon cancer. Genes Chromosomes Cancer 33: 160–167.
40. Otway R, Tetlow N, Hornby J, Kohonen‐Corish M. 2000. Evaluation of enzymatic mutation detection trade mark in hereditary nonpolyposis colorectal cancer. Hum Mutat 16: 61–67.
41. Pang Q, Prolla TA, Liskay RM. 1997. Functional domains of the Saccharomyces cerevisiae Mlh1p and Pms1p DNA mismatch repair proteins and their relevance to human hereditary nonpolyposis colorectal cancer‐associated mutations. Mol Cell Biol 17: 4465–4473.
42. Papadopoulos N, Nicolaides NC, Wei YF, Ruben SM, Carter KC, Rosen CA, Haseltine WA, Fleischmann RD, Fraser CM, Adams MD, Venter JC, Hamilton SR, Petersen GM, Watson P, Lynch HT, Peltomaki P, Mecklin JP, de la Chapelle A, Kinzler KW, Vogelstein B. 1994. Mutation of a mutL homolog in hereditary colon cancer. Science 263: 1625–1629.
43. Quehenberger F, Vasen HF, van Houwelingen HC. 2005. Risk of colorectal and endometrial cancer for carriers of mutations of the hMLH1 and hMSH2 gene: correction for ascertainment. J Med Genet 42: 491–496.
44. Raevaara TE, Korhonen MK, Lohi H, Hampel H, Lynch E, Lonnqvist KE, Holinski‐Feder E, Sutter C, McKinnon W, Duraisamy S, Gerdes AM, Peltomaki P, Kohonen‐Corish M, Mangold E, Macrae F, Greenblatt M, de la Chapelle A, Nystrom M. 2005. Functional significance and clinical phenotype of nontruncating mismatch repair variants of MLH1. Gastroenterology 129: 537–549.
45. Rodriguez‐Bigas MA, Boland CR, Hamilton SR, Henson DE, Jass JR, Khan PM, Lynch H, Perucho M, Smyrk T, Sobin L, Srivastava S. 1997. A National Cancer Institute workshop on hereditary nonpolyposis colorectal cancer syndrome: meeting highlights and Bethesda Guidelines. J Natl Cancer Inst 89: 1758–1762.
46. Samowitz WS, Curtin K, Lin HH, Robertson MA, Schaffer D, Nichols M, Gruenthal K, Leppert MF, Slattery ML. 2001. The colon cancer burden of genetically defined hereditary nonpolyposis colon cancer. Gastroenterology 121: 830–838.
47. Sasaki S, Tokino T, Miyatsu T, Muto T, Nakamura Y. 1997. Mutational analysis of the hMLH1 gene using an automated two‐dimensional DNA typing system. Hum Mutat 9: 164–171.
48. Schmutte C, Sadoff MM, Shim KS, Acharya S, Fishel R. 2001. The interaction of DNA mismatch repair proteins with human exonuclease I. J Biol Chem 276: 33011–33018.
49. Shcherbakova PV, Kunkel TA. 1999. Mutator phenotypes conferred by MLH1 overexpression and by heterozygosity for MLH1 mutations. Mol Cell Biol 19: 3177–3183.
50. Shimodaira H, Filosi N, Shibata H, Suzuki T, Radice P, Kanamaru R, Friend SH, Kolodner RD, Ishioka C. 1998. Functional analysis of human MLH1 mutations in Saccharomyces cerevisiae. Nat Genet 19: 384–389.
51. Syngal S, Fox EA, Li C, Dovidio M, Eng C, Kolodner RD, Garber JE. 1999. Interpretation of genetic test results for hereditary nonpolyposis colorectal cancer: implications for clinical predisposition testing. JAMA 282: 247–253.
52. Takahashi M, Shimodaira H, Andreutti‐Zaugg C, Iggo R, Kolodner RD, Ishioka C. 2007. Functional analysis of human MLH1 variants using yeast and in vitro mismatch repair assays. Cancer Res 67: 4595–4604.
53. Vasen HF, Mecklin JP, Khan PM, Lynch HT. 1991. The International Collaborative Group on Hereditary Non‐Polyposis Colorectal Cancer (ICG‐HNPCC). Dis Colon Rectum 34: 424–425.
54. Vasen HF, Wijnen JT, Menko FH, Kleibeuker JH, Taal BG, Griffioen G, Nagengast FM, Meijers‐Heijboer EH, Bertario L, Varesco L, Bisgaard ML, Mohr J, Fodde R, Khan PM. 1996. Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis. Gastroenterology 110: 1020–1027.
55. Wang Q, Lasset C, Desseigne F, Saurin JC, Maugard C, Navarro C, Ruano E, Descos L, Trillet‐Lenoir V, Bosset JF, Puisieux A. 1999. Prevalence of germline mutations of hMLH1, hMSH2, hPMS1, hPMS2, and hMSH6 genes in 75 French kindreds with nonpolyposis colorectal cancer. Hum Genet 105: 79–85.
56. Wijnen J, de Leeuw W, Vasen H, van der Klift H, Moller P, Stormorken A, Meijers‐Heijboer H, Lindhout D, Menko F, Vossen S, Moslein G, Tops C, Brocker‐Vriends A, Wu Y, Hofstra R, Sijmons R, Cornelisse C, Morreau H, Fodde R. 1999. Familial endometrial cancer in female carriers of MSH6 germline mutations. Nat Genet 23: 142–144.
57. Wu Y, Berends MJ, Mensink RG, Kempinga C, Sijmons RH, van Der Zee AG, Hollema H, Kleibeuker JH, Buys CH, Hofstra RM. 1999. Association of hereditary nonpolyposis colorectal cancer‐related tumors displaying low microsatellite instability with MSH6 germline mutations. Am J Hum Genet 65: 1291–1298.